Atlas Trials

Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer

Clinical trial NCT02207335 · UNKNOWN

Trial details

NCT number
NCT02207335
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2013-12-01
Primary completion
2016-11-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.